- Home
- DOCU vs HOLX Comparison
DOCU vs HOLX Comparison
Compare DOCU & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCU
- HOLX
- Stock Information
- Founded
- DOCU 2003
- HOLX 1985
- Country
- DOCU United States
- HOLX United States
- Employees
- DOCU N/A
- HOLX N/A
- Industry
- DOCU EDP Services
- HOLX Medical Electronics
- Sector
- DOCU Technology
- HOLX Health Care
- Exchange
- DOCU Nasdaq
- HOLX Nasdaq
- Market Cap
- DOCU 14.6B
- HOLX 16.5B
- IPO Year
- DOCU 2018
- HOLX 1990
- Fundamental
- Price
- DOCU $64.85
- HOLX $74.15
- Analyst Decision
- DOCU Hold
- HOLX Hold
- Analyst Count
- DOCU 17
- HOLX 15
- Target Price
- DOCU $95.62
- HOLX $79.64
- AVG Volume (30 Days)
- DOCU 2.1M
- HOLX 3.7M
- Earning Date
- DOCU 12-04-2025
- HOLX 11-03-2025
- Dividend Yield
- DOCU N/A
- HOLX N/A
- EPS Growth
- DOCU N/A
- HOLX N/A
- EPS
- DOCU 1.33
- HOLX 2.49
- Revenue
- DOCU $3,095,362,000.00
- HOLX $4,100,500,000.00
- Revenue This Year
- DOCU $9.55
- HOLX $6.23
- Revenue Next Year
- DOCU $6.78
- HOLX $5.37
- P/E Ratio
- DOCU $48.77
- HOLX $29.79
- Revenue Growth
- DOCU 8.29
- HOLX 1.74
- 52 Week Low
- DOCU $63.81
- HOLX $51.90
- 52 Week High
- DOCU $107.86
- HOLX $80.31
- Technical
- Relative Strength Index (RSI)
- DOCU 34.88
- HOLX 66.26
- Support Level
- DOCU $63.81
- HOLX $74.11
- Resistance Level
- DOCU $70.32
- HOLX $74.66
- Average True Range (ATR)
- DOCU 1.98
- HOLX 0.22
- MACD
- DOCU -0.44
- HOLX -0.26
- Stochastic Oscillator
- DOCU 9.10
- HOLX 36.65
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.